- Livestock Sectors
- Research Calls
The FishMedPlus Coalition disseminates an updated list of all fish medicines and vaccines registered in European Union. FishMedPlus is a coalition aiming for the increase of availability of authorised treatments and vaccines usable in aquaculture. Limited availability of treatments and prevention tools is a serious constraint on the health management in fish farming. The coalition solicited the EU legislator to assess the current availability of drugs and vaccines registered in aquaculture and for ornamental fish at the moment, and The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) took charge of the task.
304 different veterinary medicinal products are authorised for fish, against 10.000 for dogs and 8.000 for cattle. Half of them are vaccines, followed by antibiotics, representing the 29% of the treatments. Half of veterinary medicinal products are aimed to atlantic salmon and trouts (respectively 31% and 20%), while the 16% of them are directed towards a general category of fish.
It is possible to download the list here: http://www.hma.eu/584.html. More info here: https://www.fve.org/cms/wp-content/uploads/FishMedPlus-Newsletter-February-2019-1.pdf.
A report about the most effective strategies for eliminating lumpy skin disease (LSD) has been recently published by EFSA.
Lumpy skin disease (LSD) has recently been contained into the Balkan region showing a drop of number of diseases outbrakes by 95 percent from 2016 to 2017. The recomendation by the Standing Group of Experts to the countries in South-East Europe to collaborate with the Global Framework for the Progressive Control of Transboundary Diseases in order to draft a roadmap on a LSD exit strategy from 2018 onwards has provoked EFSA to assess the epidemiology and the effectiveness of different surveillance systems of LSD.
By using a spread epidemiological model, the report shows that only two years are sufficient to eliminate LSD virus from a territory, assuming a vaccination effectiveness of 80% and the coverage of 90% of herds, while 4 and 3 years of vaccination campaigns are needed assuming a vaccination effectiveness of 65% with 50% and 90% of herd coverage respectevly.
The report underlines the need of monitoring a large number of herds to detect the disease promptly.
EFSA suggests to cover important research gaps about the transmission of disease, duration of protective immunity, influence of vectors, dignostic tests and epidemiological status of bordering countries.
The document can be dowloaded here: https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2018.5452
Europe’s veterinary public health systems are confronted with growing economic, sociological, environmental changes and challenges. A priority-focused strategy is urgently needed to best utilize the limited resources invested into animal health research for safeguarding and improving animal health for present and future generations. A foresight study was carried out as part of the ANIHWA project in order to produce an EU Strategic Research Agenda on Animal Health and Welfare (published in 2015) and to identify topics for collaborative activities at European level. The purpose of the present study was an updateing of the previous Agenda and this report details its findings.
The European Commissioner for Health and Food Safety Vytenis Andriukaitis affirmed that european commitment to fight antimicrobial resistance has to be renew through cooperation between countries and implementing of stringent policies. Indeed, antimicrobial resistance is far to be satisfactorily faced, as the new summary report of ECDC and EFSA demonstrates, showing up the new findings based on data from 2016 .
The levels of antimicrobial resistance differ significantly from one EU country to another, and new cases of antimicrobial resistance were reported.
For the first time, ESBL-producing S. Kentucky, highly resistent to cirpofloxacin, was detected in four countries. One out of four cases of human infections given by Salmonella are due to bacteria resistent to at least three or more commonly used antimicrobials, and also Campylobacter bacteria show high resistance to widely used drugs.
Regarding the animal production, it is remarcable the finding of low levels of resistence to carbapenems in E. coli isolated on poultry and chicken meat, linezoid-resistant S. aureus found in pigs and low levels of colistin resistance in Salmonella and E. coli in pigs.